Cite Filings / TRAW / 0001104659-24-043238
Feed Companies Filings Check
Sign in
DEFA14A

Proxy Materials

Traws Pharma, Inc. · Filed 2024-04-04 · Acc 0001104659-24-043238

Documents 1

  • DEFA14A Proxy Materials , tm2410784d2_defa14a.htm

Around this filing

  • 2024-04-16 DEFA14A Proxy Materials
  • 2024-04-04 DEFA14A Proxy Materials
  • 2024-04-04 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  • 2024-04-03 4 Chief Science Officer Virology acquired 97,500 shares (grant or award)
  • 2024-04-03 3 Initial Statement of Ownership
  • 2024-04-03 3 Initial Statement of Ownership
  • 2023-07-21 DEFA14A Proxy Materials

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2410784d2_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…